AdaptHealth (AHCO) Cash & Equivalents (2017 - 2026)

AdaptHealth's Cash & Equivalents history runs 10 years deep, the most recent figure standing at $48.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 10.6% year-over-year to $48.0 million; the TTM figure through Mar 2026 stood at $48.0 million (down 10.6% YoY), while the FY2025 annual figure was $106.1 million, down 3.29% from the prior year.
• Cash & Equivalents was $48.0 million for Q1 2026 at AdaptHealth, down from $106.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $119.4 million in Q1 2022 to a low of $45.1 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $81.8 million across 5 years, with a median of $79.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents tumbled 69.08% in 2022, then soared 78.44% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $46.3 million in 2022, then jumped by 66.69% to $77.1 million in 2023, then surged by 42.28% to $109.7 million in 2024, then dropped by 3.29% to $106.1 million in 2025, then slumped by 54.81% to $48.0 million in 2026.
• The last three Cash & Equivalents figures came in at $48.0 million (Q1 2026), $106.1 million (Q4 2025), and $80.4 million (Q3 2025), per Business Quant data.